OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 23, 2019
Cambrex’s expanded quality control laboratory supports generic API development.
April 18, 2019
The expansion of the CDMO’s Skokie, IL facility includes additional refrigeration and freezer space.
The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
April 17, 2019
Contract packagers expand operations and services to accommodate growing need.
April 15, 2019
Catalent’s acquisition of Paragon Bioservices will provide expertise and in expanding gene and cell therapy markets.
April 12, 2019
Patient-centric drug development is becoming more important in the bio/pharma industry.
The new service offers a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of gene and cell therapies.
The acquisition of CiVentiChem’s facility in the United States is expected to enhance UK-based Sterling Pharma Solutions’ chemistry development capabilities.
April 09, 2019
Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility.
April 05, 2019
Sterling Pharma Solutions has acquired the US arm of complex chemistry solutions provider, CiVentiChem, which is based in Cary, North Carolina, USA.